Literature DB >> 27529429

Ready Access to the Echinopines Skeleton via Gold(I)-Catalyzed Alkoxycyclizations of Enynes.

Ruth Dorel1, Antonio M Echavarren1.   

Abstract

The [3,5,5,7] tetracyclic skeleton of echinopines has been stereoselectively accessed through a gold(I)-catalyzed alkoxycyclization of cyclopropyl-tethered 1,6-enynes. The key bicyclo[4.2.1]nonane core of the enyne precursors was readily assembled by means of a Co-catalyzed [6 + 2] cycloaddition. Furthermore, the attempted alkoxycyclization of 1,5-enyne substrates revealed an uncovered cyclopropyl rearrangement that gives rise to [3,6,5,7] tetracyclic structures.

Entities:  

Year:  2016        PMID: 27529429      PMCID: PMC5028773          DOI: 10.1021/acs.joc.6b01607

Source DB:  PubMed          Journal:  J Org Chem        ISSN: 0022-3263            Impact factor:   4.354


Introduction

Echinopines A and B (1 and 2) were isolated in 2008 from the roots of Echinops spinosus and feature an unprecedented [3,5,5,7]-membered-ring tetracyclic skeleton (Scheme ), which probably originates biosynthetically from a guaiane precursor.[1] This complex carbon framework holds five contiguous stereogenic centers, two of them being adjacent quaternary stereocenters. Despite the fact that no biological activity has been reported to date for 1 and 2, the unique architecture of these sesquiterpenes has constituted an appealing challenge for the synthetic community and several syntheses of echinopines have been accomplished to date.[2−7] The key feature in all these syntheses is the establishment of the unique [3,5,5,7] skeleton, and to this aim conceptually very different ring-forming sequences have been successfully established.[8] However, the assembly of the complex polycyclic framework of the echinopines skeleton is not easily addressed by conventional methods, as evidenced by the lengthy existing syntheses, and it is in most of the cases delayed to one of the last steps of the sequence.
Scheme 1

Strategy for the Gold-Catalyzed Synthesis of the Skeleton of Echinopines

Gold(I) catalysis constitutes a powerful tool for the construction of complex polycyclic architectures from relatively simple enyne substrates under mild reaction conditions.[9−12] A concise synthesis of the complex polycyclic framework of the echinopines skeleton could easily provide access to structural analogues for further evaluation of their biological properties. In this context, we envisioned a gold(I)-catalyzed alkoxycyclization of cyclopropyl-tethered tricyclic 1,5- (3) or 1,6-enynes (4) as the key step for the ready access to the tetracyclic skeleton of echinopines via 5-endo or 5-exo cyclization, respectively (Scheme ).[13−16] This transformation would stereoselectively lead to echinopine-based tetracyclic products bearing different groups suited for further functionalization.

Results and Discussion

Our approach for the synthesis of tricyclic enynes 3 and 4 relied on a cobalt-catalyzed [6 + 2] cycloaddition between cycloheptatriene and an internal alkyne as the key step to build the bicyclo[4.2.1]nonane core.[17,18] Thus, orthogonally protected diol 5a afforded cycloadduct 6a, which upon monodeprotection and cyclopropanation of the tetrasubstituted olefin from the less sterically hindered face gave rise to tricyclic compound 8a (Scheme ). Oxidation of the primary alcohol and subsequent homologation employing the Ohira–Bestmann reagent provided 1,5-enyne 3a.
Scheme 2

Synthesis of Tricyclic 1,5-Enyne 3a

Initial attempts to perform the alkoxycyclization of 3a with methanol as the external nucleophile in the presence of different cationic gold(I) complexes A–D only provided methyl ketone 10 as a result of the formal hydration of the terminal alkyne (Scheme ).[19−22] Moreover, when the reaction was performed under strictly anhydrous conditions, the corresponding dimethyl acetal 11 could be isolated, which rapidly decomposed to 10 under ambient conditions, thus demonstrating that the addition of methanol to the terminal alkyne of 3a is favored over the attack of the alkene moiety. Similar results were obtained when other alcohols were employed as the external nucleophiles.
Scheme 3

Formal Hydration of 3a

The use of carbonucleophiles such as indole, 1,3-diketones, and electron-rich benzenes only resulted in the recovery of unreacted 3a. Nevertheless, when the reaction of 3a was performed with commercially available gold(I) complex A in the presence of acetic acid, complete conversion of 3a was achieved in 1 h, leading to the formation of rearranged product 12 in up to 61% yield (Scheme ). A closer mechanistic inspection of this transformation suggested that the gold(I)-catalyzed reaction initially forms intermediate 14 that rearranges to form allyl cation 15, which is trapped by acetic acid. DFT calculations indicated that the formation of intermediate 16 that leads to 12 is thermodynamically favored over the formation of 17, which is predicted to be the driving force for the rearrangement to take place. This result further illustrates the influence of the cyclopropane functionality on the reaction pathways followed in the gold(I)-catalyzed cyclizations of cyclopropane-tethered 1,5-enynes[23] and underscores the propensity of the strained tetracyclic system of echinopines to undergo rearrangements.[6]
Scheme 4

Gold-Catalyzed Rearrangement of 3a

Values in parentheses correspond to relative free energies in kcal mol–1 (M06/6-31G(d) (C, H, P, O) and SDD (Au), solvent = CH2Cl2). L = PMe3.

Gold-Catalyzed Rearrangement of 3a

Values in parentheses correspond to relative free energies in kcal mol–1 (M06/6-31G(d) (C, H, P, O) and SDD (Au), solvent = CH2Cl2). L = PMe3. In order to unequivocally ensure the structure of 12, the acetate moiety was cleaved to form alcohol 18, which was converted into the corresponding crystalline p-nitrobenzoate derivative 19, whose structure was confirmed by X-ray diffraction (Scheme ).[24] In addition, a related system having one of the double bonds reduced was also examined with the aim of promoting a rearrangement toward the echinopine skeleton on the basis of the higher stability of carbocation 24 over 22 predicted by DFT calculations. Thus, 18 could be selectively hydrogenated in the presence of Crabtree’s catalyst to give 20, which was converted into tertiary carbocation 22 via triflate 21. Nonetheless, the rearranged product was not observed and only nonrearranged elimination product 23 was isolated under different reaction conditions.
Scheme 5

Synthesis of 23 from Acetate 12 and CYLview Depiction of the X-ray Crystal Structure of 19

Values in parentheses correspond to relative free energies in kcal mol–1 (M06/6-31G(d), solvent = CH2Cl2).

Synthesis of 23 from Acetate 12 and CYLview Depiction of the X-ray Crystal Structure of 19

Values in parentheses correspond to relative free energies in kcal mol–1 (M06/6-31G(d), solvent = CH2Cl2). The synthesis of the homologous 1,6-enyne 4a commenced with the cobalt-catalyzed [6 + 2] cycloaddition between cycloheptatriene and alkyne 25 followed by treatment with N-iodosuccinimide, which afforded vinyl iodide 27 (Scheme ). Kumada cross-coupling of 27 with (3-(trimethylsilyl)prop-2-yn-1-yl)magnesium bromide furnished 28, which was treated with HF·py to give allylic alcohol 29. Cyclopropanation of the tetrasubstituted olefin followed by deprotection of the terminal alkyne and protection of the primary alcohol gave rise to tricyclic 1,6-enyne 4a. However, all attempts to perform the alkoxycyclization of 4a in the presence of different gold(I) complexes provided only traces of the cyclized tetracyclic product and resulted in the formation of methyl ketone 31 as the major product.
Scheme 6

Synthesis and Formal Hydration of Tricyclic 1,6-Enyne 4a

Aldehydes 9a,b[25] were next employed as the platform to access a series of tricyclic 1,6-enynes featuring different functionalities at the propargylic position. Thus, the addition of ethynylmagnesium bromide provided 4b,c as single diastereoisomers and their alkoxycyclization was investigated using methanol as the external nucleophile in the presence of a series of gold(I) complexes spanning a range of electrophilicities. The desired alkoxycyclization products could only be detected from the reactions carried out in the presence of phosphine–gold(I) complexes, whereas gold(I) complexes bearing NHC and phosphite ligands gave complex mixtures.[26] Cationic gold(I) complex B provided the best results, and the use of the alcohol as the solvent proved to be optimal for the alkoxycyclization of enynes 4b,c to afford regio- and stereoselectively tetracyclic products 32a–c, which feature the [3,5,5,7] tetracyclic skeleton of echinopines (Scheme ). While the reaction of 4b with methanol provided 32a as a single regioisomer, the analogous reaction of 4c gave rise to a 5:1 mixture of regioisomers. Nonetheless, changing the external nucleophile from methanol to allyl alcohol in the reaction of 4c resulted in the exclusive formation of 32c as the sole isomer. The structure of tetracycles 32a–c could be confirmed from the X-ray crystal structure of 32a.[24]
Scheme 7

Synthesis and Alkoxycyclization of 4b,c and CYLview Depiction of the X-ray Crystal Structure of 32a

Interestingly, the propargylic alcohol of enynes 4b,c was substituted by a second molecule of alcohol in the gold(I)-catalyzed cyclization process. In order to elucidate the order of events in this transformation, the closely related system 34 in which the 1,3-diene had been reduced to the corresponding alkane was submitted to the optimized reaction conditions for the gold(I)-catalyzed alkoxycyclization (Scheme ). However, after 2 h only hydroxyketone 35 and unreacted 34 were detected from the crude mixture and no substitution of the propargylic alcohol was observed.[26] This result supports a catalytic cycle in which the propargylic alcohol in 4b,c is eliminated after the cyclization of the enyne by the attack of a molecule of methanol to intermediate 36, which generates α,β-unsaturated gold(I) carbene intermediate 37.[27] The attack of a second molecule of alcohol to 37 forms 38, which releases tetracycles 32 by protodeauration (Scheme ).
Scheme 8

Synthesis of 34 and Gold(I)-Catalyzed Reaction under the Optimized Alkoxycyclization Reaction Conditions

Scheme 9

Catalytic Cycle for the Alkoxycyclization of 4b,c

Ketoenynes 4d,e were also prepared by direct oxidation of 4b,c, and their alkoxycyclization under the optimized reaction conditions provided mixtures of the two possible regioisomeric products 39a′,b′ and 39a″,b″,[28] which could be separated by preparative chromatography (Scheme ). Water could also be used as the external nucleophile to afford inseparable mixtures of regioisomeric allylic alcohols 39c′,d′/39c″,d″ in moderate yields.
Scheme 10

Synthesis and Alkoxycyclization of 4d,e

Conclusion

In summary, the [3,5,5,7] tetracyclic core of echinopines can be readily accessed through the gold(I)-catalyzed alkoxycyclization of tricyclic cyclopropyl-tethered 1,6-enynes bearing an O functionality at the propargylic position, giving access to functionalized echinopine analogues as single stereoisomers. Furthermore, the cyclization of 1,5-enyne 3a uncovered an unexpected migration of the cyclopropane functionality, thus providing access to the complex natural-product-like [3,6,5,7] tetracycle 12.

Experimental Section

General Remarks

Chemicals and solvents for chromatography were used as received. Solvents used in reactions under an inert atmosphere were dried by passing through an activated alumina column on a solvent purification system. Analytical thin-layer chromatography was carried out using TLC-aluminum sheets with 0.2 mm of silica gel (Merck FG254) with UV light as the visualizing agent or an acidic solution of vanillin in ethanol as the developing agent. Purifications by chromatography were carried out using flash grade silica gel (SDS Chromatogel 60 ACC, 40–60 mm). Preparative TLC was performed on 20 cm × 20 cm silica gel plates. Organic solutions were concentrated under reduced pressure on a rotary evaporator. NMR spectra were recorded at 298 K on 300, 400, and 500 MHz devices. 1H and 13C chemical shifts (δ) are given in ppm relative to TMS, and coupling constants (J) in Hz. Mass spectra were recorded employing TOF mass analyzers (ESI, APCI). Melting points were determined by observation of the fusion of the solids placed in a capillary, through a magnifying glass. Crystal structure determinations were carried out using a diffractometer equipped with an APPEX 2 4K CCD area detector, an FR591 rotating anode with Mo Kα radiation, Montel mirrors as the monochromator, and a Kryoflex low temperature device (T = −173 °C). Full-sphere data collection was used with ω and φ scans. Programs used: data collection APEX-2, data reduction Bruker Saint V/.60A, and absorption correction SADABS. Structure solution and refinement: crustal structure solution was achieved using direct methods as implemented in SHELXTL and visualized using the program XP. Missing atoms were subsequently located from difference Fourier synthesis and added to the atom list. Least-squares refinement on F2 using all measured intensities was carried out using the program SHELXTL. All non-hydrogen atoms were refined including anisotropic displacement parameters.

tert-Butyl((4-methoxybut-2-yn-1-yl)oxy)dimethylsilane (5a)

NaH (60% in mineral oil, 1.89 g, 47.2 mmol) was added to a solution of 4-((tert-butyldimethylsilyl)oxy)but-2-yn-1-ol[29] (8.60 g, 42.9 mmol) in anhydrous THF (210 mL) under argon at 0 °C. The resulting suspension was stirred for 30 min, and then methyl iodide (3.2 mL, 51.5 mmol) was slowly added. The reaction mixture was warmed to room temperature and then stirred for 1.5 h. After it was diluted with Et2O (100 mL), the mixture was washed with a saturated solution of NH4Cl (150 mL) and water (150 mL), the aqueous layers were extracted with Et2O (2 × 100 mL), and the combined organic layers were dried over MgSO4, filtered, and concentrated under reduced pressure. The product was obtained after purification by flash chromatography (cyclohexane/EtOAc 95/5) as a clear oil (8.00 g, 37.3 mmol, yield 87%). 1H NMR (400 MHz, CDCl3): δ 4.38 (t, J = 1.8 Hz, 2H), 4.15 (t, J = 1.8 Hz, 2H), 3.40 (s, 3H), 0.93 (s, 9H), 0.14 (s, 6H). 13C NMR (101 MHz, CDCl3): δ 85.1, 80.6, 60.0, 57.6, 51.7, 25.8, 18.3, −5.2. HRMS (ESI+): m/z calcd for C11H22NaO2Si [M + Na]+, 237.1281; found, 237.1278.

Synthesis of 6

CoBr2 (306.1 mg, 1.40 mmol), Zn (366.1 mg, 5.60 mmol), and ZnI2 (1.79 g, 5.60 mmol) were suspended in anhydrous 1,2-dichloroethane (20 mL) under argon. Then P(OiPr)3 (0.69 mL, 2.80 mmol) was added, followed by cycloheptatriene (4.36 mL, 41.98 mmol) and a solution of 5(30) (27.99 mmol) in dry 1,2-dichloroethane (8 mL). The resulting mixture was stirred at 50 °C for 16 h and then filtered through a pad of Celite and concentrated under reduced pressure. Purification of the resulting crude by flash chromatography (cyclohexane/EtOAc 1/0 to 95/5) afforded compounds 6.

tert-Butyl(((1R*,6S*)-8-(methoxymethyl)bicyclo[4.2.1]nona-2,4,7-trien-7-yl)methoxy)dimethylsilane (6a)

Pale yellow oil (6.69 g, 21.83 mmol, yield 78%). 1H NMR (300 MHz, CDCl3): δ 6.29–6.11 (m, 2H), 5.84–5.74 (m, 2H), 4.35 (d, J = 13.1 Hz, 1H), 4.23 (d, J = 13.1 Hz, 1H), 4.12 (d, J = 12.3 Hz, 1H), 3.92 (d, J = 12.3 Hz, 1H), 3.41 (t, J = 7.1 Hz, 1H), 3.32 (d, J = 7.1 Hz, 1H), 3.27 (s, 3H), 2.29–2.17 (m, 1H), 1.61 (d, J = 11.6 Hz, 1H), 0.93 (s, 9H), 0.08 (s, 3H), 0.07 (s, 3H). 13C NMR (75 MHz, CDCl3): δ 139.8, 139.8, 138.4, 132.1, 124.3, 124.2, 66.2, 57.8, 57.2, 45.4, 44.7, 30.0, 25.9, 18.4, −5.3, −5.4. HRMS (ESI+): m/z calcd for C18H30NaO2Si [M + Na]+, 329.1907; found, 329.1904.

(((1R*,6S*)-8-((Benzyloxy)methyl)bicyclo[4.2.1]nona-2,4,7-trien-7-yl)methoxy) (tert-butyl)dimethylsilane (6b)

Colorless oil (5.89 g, 15.39 mmol, yield 55%). 1H NMR (300 MHz, CDCl3): δ 7.40–7.29 (m, 5H), 6.26–6.14 (m, 2H), 5.84–5.74 (m, 2H), 4.48 (d, J = 11.8 Hz, 1H), 4.41 (d, J = 11.9 Hz, 1H), 4.32 (d, J = 13.0 Hz, 1H), 4.20 (d, J = 12.6 Hz, 2H), 4.04 (d, J = 12.4 Hz, 1H), 3.43 (t, J = 7.1 Hz, 1H), 3.37 (t, J = 7.1 Hz, 1H), 2.25 (dt, J = 12.7, 6.7 Hz, 1H), 1.62 (d, J = 11.4 Hz, 1H), 0.92 (s, 9H), 0.07 (s, 3H), 0.07 (s, 3H). 13C NMR (126 MHz, CDCl3): δ 139.9, 139.8, 138.5, 138.5, 132.1, 128.3, 127.8, 127.5, 124.3, 124.3, 71.7, 63.7, 57.2, 45.5, 44.7, 30.0, 25.9, 18.4, −5.3, −5.4. HRMS (ESI+): m/z calcd for C24H34NaO2Si [M + Na]+, 405.2220; found, 405.2230.

Synthesis of 7

TBAF (1.0 M in THF, 22.8 mL, 22.8 mmol) was added to a solution of 6 (11.4 mmol) in anhydrous THF (200 mL) at 0 °C under argon. The mixture was stirred at room temperature for 2 h and then diluted with Et2O (100 mL) and washed with saturated solution of NH4Cl (150 mL) and water (150 mL). The aqueous layers were extracted with Et2O (2 × 100 mL), and the combined organic layers were dried over MgSO4, filtered, and concentrated under reduced pressure. Purification by flash chromatography (cyclohexane/EtOAc 7/3) afforded products 7.

((1R*,6S*)-8-(Methoxymethyl)bicyclo[4.2.1]nona-2,4,7-trien-7-yl)methanol (7a)

Colorless oil (1.62 g, 8.4 mmol, yield 74%). 1H NMR (400 MHz, CDCl3): δ 6.30–6.14 (m, 2H), 5.89–5.78 (m, 2H), 4.30 (dd, J = 13.2, 6.3 Hz, 1H), 4.24 (dd, J = 13.2, 4.9 Hz, 1H), 4.17 (d, J = 12.6 Hz, 1H), 4.00 (d, J = 12.4 Hz, 1H), 3.38–3.26 (m, 2H), 3.32 (s, 3H), 2.26 (dtt, J = 11.5, 6.8, 1.3 Hz, 1H), 1.95 (t, J = 5.7 Hz, 1H), 1.61 (d, J = 11.4 Hz, 1H). 13C NMR (101 MHz, CDCl3): δ 139.3, 139.3, 137.6, 133.3, 124.6, 125,6, 66.6, 58.1, 57.6, 45.7, 45.7, 30.0. HRMS (ESI+): m/z calcd for C12H16NaO2 [M + Na]+, 215.1043; found, 215.1042.

((1R*,6S*)-8-((Benzyloxy)methyl)bicyclo[4.2.1]nona-2,4,7-trien-7-yl)methanol (7b)

Colorless oil (2.29 g, 8.55 mmol, yield 75%). 1H NMR (500 MHz, CDCl3): δ 7.41–7.30 (m, 5H), 6.28–6.16 (m, 2H), 5.86–5.84 (m, 1H), 5.84–5.81 (m, 1H), 4.52 (d, J = 11.8 Hz, 1H), 4.46 (d, J = 11.8 Hz, 1H), 4.31–4.19 (m, 3H), 4.11 (d, J = 12.5 Hz, 1H), 3.35 (t, J = 7.0 Hz, 2H), 2.27 (dtt, J = 11.5, 6.8, 1.2 Hz, 1H), 1.76 (s, 1H), 1.63 (d, J = 11.4 Hz, 1H). 13C NMR (101 MHz, CDCl3): δ 139.4, 139.4, 138.1, 137.7, 133.5, 128.4, 127.8, 127.7, 124.6, 124.6, 72.2, 63.9, 57.5, 45.7, 45.7, 30.0. HRMS (ESI+): m/z calcd for C18H20NaO2 [M + Na]+, 291.1356; found, 291.1365.

Synthesis of 8

Diiodomethane (0.61 mL, 7.57 mmol) and ZnEt2 (1.0 M in hexanes, 15.75 mL, 15.75 mmol) were added to a solution of 7 (6.30 mmol) in anhydrous CH2Cl2 (210 mL) at 0 °C. The resulting mixture was warmed to room temperature and stirred until TLC analysis showed complete disappearance of the starting material (5–12 h). The reaction mixture was quenched by the slow addition of a saturated aqueous Na/K-tartrate solution (100 mL), and after it was stirred for 30 min the organic layer was separated, the aqueous layer was extracted with CH2Cl2 (100 mL), and the combined organic phases were dried over MgSO4 and concentrated under reduced pressure. Purification by flash chromatography (cyclohexane/EtOAc 7/3) afforded products 8.

((1R*,6S*,7R*,9S*)-9-(Methoxymethyl)tricyclo[4.3.1.07,9]deca-2,4-dien-7-yl)methanol (8a)

Colorless oil (1.22 g, 5.92 mmol, yield 94%). 1H NMR (500 MHz, CDCl3): δ 6.11–6.00 (m, 2H), 5.85–5.74 (m, 2H), 4.01 (dd, J = 10.0, 1.2 Hz, 1H), 3.84 (d, J = 11.7 Hz, 1H), 3.67 (d, J = 11.7 Hz, 1H), 3.38 (s, 3H), 3.10 (d, J = 10.0 Hz, 1H), 2.86–2.78 (m, 2H), 2.01 (dtt, J = 12.8, 6.3, 1.3 Hz, 1H), 1.78 (d, J = 13.1 Hz, 1H), 1.73 (d, J = 13.0 Hz, 1H), 0.81 (d, J = 5.6 Hz, 1H), 0.26 (d, J = 5.6 Hz, 1H). 13C NMR (101 MHz, CDCl3): δ 137.3, 136.5, 125.9, 125.0, 73.4, 64.2, 58.8, 42.1, 42.0, 41.4, 39.6, 26.6, 14.4. HRMS (ESI+): m/z calcd for C13H18NaO2 [M + Na]+, 229.1199; found, 229.1207.

((1R*,6S*,7R*,9S*)-9-((Benzyloxy)methyl)tricyclo[4.3.1.07,9]deca-2,4-dien-7-yl)methanol (8b)

Colorless oil (1.53 g, 5.42 mmol, yield 86%). 1H NMR (500 MHz, CDCl3): δ 7.39–7.33 (m, 4H), 7.32–7.29 (m, 1H), 6.10–6.04 (m, 1H), 6.01–5.95 (m, 1H), 5.81–5.70 (m, 2H), 4.59 (d, J = 12.1 Hz, 1H), 4.52 (d, J = 12.1 Hz, 1H), 4.08 (dd, J = 10.0, 1.2 Hz, 1H), 3.82 (dd, J = 11.7, 7.0 Hz, 1H), 3.63 (d, J = 11.6 Hz, 1H), 3.21 (d, J = 10.0 Hz, 1H), 2.87 (t, J = 6.2 Hz, 1H), 2.81 (t, J = 6.2 Hz, 1H), 2.01 (dtt, J = 12.8, 6.3, 1.3 Hz, 1H), 1.79 (d, J = 13.0 Hz, 1H), 1.68 (s, 1H), 0.83 (d, J = 5.6 Hz, 1H), 0.26 (d, J = 5.6 Hz, 1H). 13C NMR (126 MHz, CDCl3): δ 138.5, 137.3, 136.5, 128.4, 127.7, 127.6, 125.9, 125.0, 72.9, 70.9, 64.3, 42.1, 42.1, 41.5, 39.7, 26.6, 14.6. HRMS (ESI+): m/z calcd for C19H22NaO2 [M + Na]+, 305.1512; found, 305.1517.

Synthesis of 9

Dess–Martin periodinane (2.67 g, 6.30 mmol) was added to a solution of 8 (4.85 mmol) in CH2Cl2 (50 mL). After the addition of 1 drop of water the resulting suspension was stirred at room temperature for 1 h and then washed with a 1/1 mixture of a saturated solution of Na2S2O3/Na2CO3 (40 mL). The organic layer was dried over MgSO4, filtered, and concentrated under reduced pressure. The product was obtained after purification by flash chromatography (cyclohexane/EtOAc 7/3).

(1R*,6S*,7R*,9S*)-9-(Methoxymethyl)tricyclo[4.3.1.07,9]deca-2,4-diene-7-carbaldehyde (9a)

Colorless oil (871.7 mg, 4.27 mmol, yield 88%). 1H NMR (500 MHz, CDCl3): δ 9.39 (s, 1H), 6.31 (ddq, J = 11.4, 7.5, 1.0 Hz, 1H), 5.99 (ddq, J = 12.3, 7.5, 1.0 Hz, 1H), 5.79 (ddd, J = 11.4, 7.4, 0.9 Hz, 1H), 5.72 (ddd, J = 12.3, 7.4, 0.8 Hz, 1H), 3.95 (dd, J = 9.9, 1.4 Hz, 1H), 3.40 (s, 3H), 3.35 (d, J = 9.9 Hz, 1H), 3.00–2.95 (m, 1H), 2.88 (t, J = 7.0 Hz, 1H), 2.05 (dtt, J = 12.9, 6.4, 1.3 Hz, 1H), 1.91 (d, J = 13.2 Hz, 1H), 1.25 (d, J = 5.8 Hz, 1H), 1.19 (dd, J = 5.8, 1.6 Hz, 1H). 13C NMR (126 MHz, CDCl3): δ 200.0, 136.6, 134.8, 125.7, 124.5, 71.5, 58.9, 51.8, 46.0, 41.3, 39.4, 26.5, 17.5. HRMS (ESI+): m/z calcd for C13H16NaO2 [M + Na]+, 227.1043; found, 227.1040.

(1R*,6S*,7R*,9S*)-9-((Benzyloxy)methyl)tricyclo[4.3.1.07,9]deca-2,4-diene-7-carbaldehyde (9b)

Colorless oil (1.06 g, 3.78 mmol, yield 78%). 1H NMR (500 MHz, CDCl3): δ 9.36 (s, 1H), 7.42–7.34 (m, 4H), 7.34–7.29 (m, 1H), 6.33–6.27 (m, 1H), 5.97–5.89 (m, 1H), 5.78–5.67 (m, 2H), 4.60 (d, J = 11.9 Hz, 1H), 4.52 (d, J = 11.9 Hz, 1H), 4.04 (dd, J = 9.9, 1.3 Hz, 1H), 3.48 (d, J = 9.8 Hz, 1H), 2.97 (dd, J = 7.5, 6.3 Hz, 1H), 2.93 (t, J = 7.0 Hz, 1H), 2.06 (dtt, J = 12.9, 6.4, 1.3 Hz, 1H), 1.91 (d, J = 13.2 Hz, 1H), 1.26 (d, J = 5.8 Hz, 1H), 1.21 (dd, J = 5.9, 1.3 Hz, 1H). 13C NMR (126 MHz, CDCl3): δ 199.9, 138.2, 136.6, 134.8, 128.4, 127.7, 125.7, 124.4, 73.2, 69.2, 51.9, 46.1, 41.4, 39.4, 26.4, 17.7. HRMS (ESI+): m/z calcd for C19H20NaO2 [M + Na]+, 303.1356; found, 303.1361.

(1R*,6S*,7S*,9S*)-7-Ethynyl-9-(methoxymethyl)tricyclo[4.3.1.07,9]deca-2,4-diene (3a)

Ohira–Bestmann reagent (790 mg, 4.98 mmol) and K2CO3 (947.3 mg, 6.85 mmol) were sequentially added to a solution of 9a (700 mg, 3.43 mmol) in MeOH (34 mL), and the resulting mixture was stirred at room temperature for 16 h. Then the volatiles were removed under reduced pressure and the residue was dissolved in EtOAc (30 mL) and washed with water (30 mL) and brine (30 mL). The organic layer was dried over MgSO4, filtered, and concentrated under reduced pressure. Purification by flash chromatography (cyclohexane/EtOAc 85/15) afforded the product as a colorless oil (391.6 mg, 1.96 mmol, yield 57%). 1H NMR (500 MHz, CDCl3): δ 6.09–5.96 (m, 2H), 5.85–5.78 (m, 2H), 4.09 (dd, J = 10.2, 1.6 Hz, 1H), 3.40 (s, 3H), 3.10 (d, J = 10.2 Hz, 1H), 2.82 (dd, J = 6.7, 5.2 Hz, 1H), 2.80 (dd, J = 6.4, 5.3 Hz, 1H), 2.00–1.92 (m, 1H), 1.98 (s, 1H), 1.85 (dd, J = 13.2, 0.6 Hz, 1H), 0.98 (dd, J = 5.7, 1.6 Hz, 1H), 0.57 (d, J = 5.6 Hz, 1H). 13C NMR (126 MHz, CDCl3): δ 136.5, 135.6, 125.6, 125.0, 84.5, 74.2, 67.3, 58.8, 42.3, 40.6, 40.5, 30.0, 26.7, 17.2. HRMS (APCI+): m/z calcd for C14H17O [M + H]+, 201.1274; found, 201.1271.

1-((1R*,6S*,7R*,9S*)-9-(Methoxymethyl)tricyclo[4.3.1.07,9]deca-2,4-dien-7-yl)ethan-1-one (10)

To a solution of 3a (20.0 mg, 0.1 mmol) in MeOH (1 mL) was added gold(I) complex B(31) (7.9 mg, 0.005 mmol), and the resulting mixture was stirred at room temperature for 2 h. The reaction was quenched by the addition of 1 drop of Et3N, and the volatiles were removed under reduced pressure. Purification by column chromatography (cyclohexane/EtOAc 8/2) afforded the product as a colorless oil (21.6 mg, 0.099 mmol, yield 99%). 1H NMR (400 MHz, CDCl3): δ 6.12–6.02 (m, 2H), 5.82–5.70 (m, 2H), 3.96 (dd, J = 10.2, 1.4 Hz, 1H), 3.66 (d, J = 10.2 Hz, 1H), 3.40 (s, 3H), 3.03 (dd, J = 7.4, 6.5 Hz, 1H), 2.86 (dd, J = 7.4, 6.4 Hz, 1H), 2.29 (s, 3H), 2.05 (dddd, J = 13.0, 6.5, 5.1, 1.4 Hz, 1H), 1.82 (d, J = 13.2 Hz, 1H), 1.11 (dd, J = 5.0, 1.4 Hz, 1H), 0.83 (d, J = 5.0 Hz, 1H). 13C NMR (101 MHz, CDCl3): δ 207.9, 136.5, 135.5, 124.9, 124.9, 72.1, 58.8, 49.4, 44.3, 41.3, 40.9, 31.5, 25.9, 20.8. HRMS (ESI+): m/z calcd for C14H18NaO2 [M + Na]+, 241.1199; found, 241.1193.

Isolation of the Acetal Intermediate (1R*,6S*,7R*,9S*)-7-(1,1-Dimethoxyethyl)-9-(methoxymethyl)tricyclo[4.3.1.07,9]deca-2,4-diene (11)

Inside a glovebox, 3a (20 mg, 0.1 mmol) was dissolved in anhydrous and degassed CH2Cl2 (1 mL) and then anhydrous MeOH (41 μL, 1 mmol) and gold(I) complex B (7.9 mg, 0.005 mmol) were sequentially added. The resulting mixture was stirred at room temperature for 30 min and then quenched by the addition of 1 drop of Et3N. After removal of the volatiles under reduced pressure, filtration through a pad of basic Al2O3 afforded the product as an unstable colorless oil. 1H NMR (300 MHz, CDCl3): δ 6.10–5.99 (m, 2H), 5.80–5.64 (m, 2H), 3.89 (dd, J = 9.6, 1.4 Hz, 1H), 3.40 (s, 3H), 3.36 (d, J = 9.5 Hz, 1H), 3.20 (s, 3H), 3.04 (s, 3H), 2.83 (t, J = 6.7 Hz, 1H), 2.73 (dd, J = 7.7, 6.6 Hz, 1H), 2.06 (dt, J = 12.8, 6.4 Hz, 1H), 1.75 (d, J = 13.0 Hz, 1H), 1.40 (s, 3H), 0.80 (d, J = 5.1 Hz, 1H), 0.63 (dd, J = 5.1, 1.3 Hz, 1H). 13C NMR (126 MHz, CDCl3): δ 138.4, 136.5, 125.4, 124.4, 100.7, 72.5, 58.8, 48.8, 48.0, 42.3, 42.1, 29.7, 27.4, 23.2, 17.6, 12.1. HRMS could not be obtained due to decomposition to 10.

(1R*,1aR*,3R*,5aR*)-1-(Methoxymethyl)-1,1a,2,2a,5a,7a-hexahydro-3H-1,3-methanocyclopropa[f]azulen-3-yl Acetate (12)

Gold(I) complex A (38.6 mg, 0.05 mmol) was added to a solution of 3a (200.3 mg, 1 mmol) and AcOH (0.57 mL, 10 mmol) in CH2Cl2 (10 mL), and the resulting mixture was stirred at room temperature for 1 h. The reaction was quenched by the addition of 1 drop of Et3N, and the volatiles were removed under reduced pressure. Purification by column chromatography (cyclohexane/EtOAc 95/5 to 8/2) afforded the product as a colorless oil (158.8 mg, 0.61 mmol, dr = 5:1, yield 61%). Data for the major isomer are as follows. 1H NMR (400 MHz, CDCl3): δ 6.53 (dt, J = 6.0, 0.9 Hz, 1H), 5.74 (dd, J = 5.9, 3.1 Hz, 1H), 5.62 (ddd, J = 12.5, 7.9, 2.0 Hz, 1H), 5.28 (ddd, J = 12.4, 4.3, 1.4 Hz, 1H), 3.32 (s, 3H), 3.29 (d, J = 10.0 Hz, 1H), 3.12 (d, J = 10.0 Hz, 1H), 3.03–2.97 (m, 1H), 2.70 (dd, J = 16.8, 1.5 Hz, 1H), 2.48–2.42 (m, 1H), 2.33 (ddd, J = 14.5, 7.4, 5.1 Hz, 1H), 2.06 (s, 3H), 2.05 (d, J = 14.6 Hz, 1H), 1.65 (d, J = 11.2 Hz, 1H), 1.39–1.34 (m, 1H), 1.19 (t, J = 8.5 Hz, 1H). 13C NMR (101 MHz, CDCl3): δ 170.6, 137.6, 133.4, 126.8, 123.5, 85.9, 81.4, 58.1, 47.4, 42.8, 31.7, 28.1, 24.5, 22.1, 21.7, 19.1. HRMS (ESI+): m/z calcd for C16H20NaO3 [M + Na]+, 283.1305; found, 283.1307.

(1R*,1aR*,3R*,5aR*)-1-(Methoxymethyl)-1,1a,2,2a,5a,7a-hexahydro-3H-1,3-methanocyclopropa[f]azulen-3-ol (18)

K2CO3 (253.9 mg, 1.92 mmol) was added to a solution of 12 (100 mg, 0.38 mmol) in a 1/1 mixture of CH2Cl2 and MeOH (4 mL), and the resulting mixture was stirred at 50 °C for 16 h. After the mixture was cooled to room temperature, the volatiles were removed under reduced pressure and the resulting crude was purified by column chromatography (cyclohexane/EtOAc 7/3 to 1/1) to give the product as a colorless oil (69.7 mg, 0.32 mmol, dr > 20:1, yield 84%). 1H NMR (400 MHz, CDCl3): δ 6.00 (dt, J = 5.8, 0.9 Hz, 1H), 5.68 (dd, J = 5.8, 3.2 Hz, 1H), 5.61 (ddd, J = 12.5, 7.9, 2.0 Hz, 1H), 5.29 (ddd, J = 12.4, 4.3, 1.4 Hz, 1H), 3.35 (s, 3H), 3.31 (d, J = 9.8 Hz, 1H), 3.15 (d, J = 9.8 Hz, 1H), 3.06–2.97 (m, 1H), 2.37 (ddd, J = 14.5, 7.4, 5.2 Hz, 1H), 2.19 (dd, J = 15.9, 1.5 Hz, 1H), 2.11 (t, J = 7.1 Hz, 1H), 2.02 (d, J = 14.6 Hz, 1H), 1.78 (s, 1H), 1.68 (d, J = 15.9 Hz, 1H), 1.36 (ddd, J = 9.0, 5.4, 1.3 Hz, 1H), 1.19 (t, J = 8.4 Hz, 1H). 13C NMR (101 MHz, CDCl3): δ 141.4, 132.6, 127.1, 123.3, 81.8, 77.9, 58.4, 48.8, 45.7, 35.0, 28.3, 24.6, 21.7, 18.9. HRMS (ESI+): m/z calcd for C14H18NaO2 [M + Na]+, 241.1199; found, 241.1205.

(1R*,1aR*,3R*,5aR*)-1-(Methoxymethyl)-1,1a,2,2a,5a,7a-hexahydro-3H-1,3-methanocyclopropa[f]azulen-3-yl 4-Nitrobenzoate (19)

4-Nitrobenzoyl chloride (30.6 mg, 0.16 mmol) was added to a solution of 18 (30 mg, 0.14 mmol), Et3N (38 μL, 0.27 mmol), and DMAP (1.2 mg, 0.01 mmol) in anhydrous CH2Cl2 (3 mL), and the mixture was stirred at room temperature for 1 h and then washed with H2O (2 × 5 mL). The organic layer was dried over MgSO4, filtered, and concentrated under reduced pressure. Purification by column chromatography (cyclohexane/EtOAc 9/1) afforded the product as a white solid (51.3 mg, 0.14 mmol, yield quantitative). Mp: 136–138 °C. 1H NMR (500 MHz, CDCl3): δ 8.32–8.29 (m, 2H), 8.24–8.20 (m, 2H), 6.63 (dt, J = 5.9, 0.9 Hz, 1H), 5.84 (dd, J = 5.9, 3.1 Hz, 1H), 5.68 (ddd, J = 12.5, 8.0, 2.1 Hz, 1H), 5.34 (ddd, J = 12.4, 4.2, 1.1 Hz, 1H), 3.32 (d, J = 10.0 Hz, 1H), 3.25 (s, 3H), 3.12–3.09 (m, 1H), 3.11 (d, J = 10.0 Hz, 1H), 2.84 (dd, J = 16.9, 1.6 Hz, 1H), 2.73–2.68 (m, 1H), 2.43 (ddd, J = 14.7, 7.4, 5.2 Hz, 1H), 2.16 (d, J = 14.7 Hz, 1H), 1.80 (d, J = 16.8 Hz, 1H), 1.44 (dd, J = 8.9, 5.2 Hz, 1H), 1.29–1.23 (m, 1H). 13C NMR (126 MHz, CDCl3): δ 163.9, 150.4, 137.0, 136.9, 134.0, 130.6, 126.7, 123.7, 123.5, 88.0, 81.3, 58.2, 47.5, 42.7, 32.0, 28.1, 24.5, 21.7, 19.3. HRMS (ESI+): m/z calcd for C21H21NNaO5 [M + Na]+, 390.1312; found, 390.1315.

(1R*,1aR*,3S*,5aS*)-1-(Methoxymethyl)-1,1a,2,2a,4,5,5a,7a-octahydro-3H-1,3-methanocyclopropa[f]azulen-3-ol (20)

A round-bottom flask containing a solution of 18 (50 mg, 0.23 mmol) and Crabtree’s catalyst (3.7 mg, 0.0046 mmol) in anhydrous MeOH (3 mL) was evacuated and back-filled with H2 (repeated three times). The resulting mixture was stirred at room temperature for 1 h, then the volatiles were removed under reduced pressure, and the crude waqs purified by column chromatography (cyclohexane/EtOAc 1/1) to afford the product as a yellow oil (46.0 mg, 0.21 mmol, yield 91%). 1H NMR (400 MHz, CDCl3): δ 5.47–5.36 (m, 2H), 3.41–3.33 (m, 1H), 3.37 (s, 3H), 2.99 (d, J = 9.3 Hz, 1H), 2.54–2.46 (m, 1H), 2.29–2.20 (m, 1H), 2.06–1.96 (m, 1H), 1.95–1.85 (m, 4H), 1.77–1.58 (m, 4H), 1.38–1.24 (m, 2H). 13C NMR (101 MHz, CDCl3): δ 135.6, 120.0, 82.0, 74.6, 58.7, 43.5, 40.1, 38.6, 31.5, 29.3, 24.2, 22.4, 21.4, 18.4. HRMS (ESI+): m/z calcd for C14H20NaO2 [M + Na]+, 243.1356; found, 243.1355.

(1R*,1aR*,5aS*)-1-(Methoxymethyl)-1a,2,2a,5,5a,7a-hexahydro-1H-1,3-methanocyclopropa[f]azulene (23)

Tf2O (37 μL, 0.22 mmol) was slowly added to a solution of 20 (40 mg, 0.18 mmol), pyridine (29 μL, 0.36 mmol), and DMAP (2.2 mg, 0.018 mmol) in anhydrous CH2Cl2 (2 mL) at 0 °C. The reaction mixture was warmed to room temperature and after stirring for 1 h was quenched by the addition of H2O (2 mL). The organic layer was separated, dried over MgSO4, filtered, and concentrated under reduced pressure. Purification by column chromatography (cyclohexane/EtOAc 98/2) afforded the product as a yellow oil (35.6 mg, 0.18 mmol, yield 98%). 1H NMR (400 MHz, CDCl3): δ 5.51 (bs, 1H), 5.44 (ddd, J = 12.4, 7.3, 1.7 Hz, 1H), 5.40–5.34 (m, 1H), 3.63 (d, J = 9.9 Hz, 1H), 3.40 (s, 3H), 3.28 (d, J = 9.9 Hz, 1H), 2.55–2.49 (m, 1H), 2.27–2.11 (m, 5H), 2.05–2.00 (m, 1H), 1.77–1.73 (m, 1H), 1.72–1.65 (m, 1H), 1.56 (t, J = 8.1, 7.6 Hz, 1H). 13C NMR (101 MHz, CDCl3): δ 147.9, 134.1, 121.3, 118.1, 79.6, 58.6, 44.1, 38.5, 36.7, 33.8, 30.8, 27.9, 27.8, 21.0. HRMS (ESI+): m/z calcd for C14H18NaO [M + Na]+, 225.1250; found, 225.1243.

tert-Butyldiphenyl(((1R*,6S*)-8-(trimethylsilyl)bicyclo[4.2.1]nona-2,4,7-trien-7-yl)methoxy)silane (26)

CoBr2 (238.6 mg, 1.09 mmol), Zn (285.4 mg, 4.36 mmol), and ZnI2 (1.39 g, 4.36 mmol) were suspended in anhydrous 1,2-dichloroethane (35 mL) under argon. Then P(OPr)3 (0.54 mL, 2.18 mmol) was added, followed by cycloheptatriene (3.40 mL, 32.73 mmol) and a solution of 25(32) (8.00 g, 21.82 mmol) in anhydrous 1,2-dichloroethane (9 mL). The resulting mixture was stirred at 50 °C for 30 h and then filtered through a short pad of silica gel and concentrated under reduced pressure. Purification by flash chromatography (cyclohexane/EtOAc 1/0 to 95/5) afforded the product as a colorless oil (7.10 g, 15.49 mmol, yield 71%). 1H NMR (500 MHz, CDCl3): δ 7.74–7.68 (m, 4H), 7.48–7.39 (m, 6H), 6.16–6.10 (m, 1H), 6.09–6.03 (m, 1H), 5.83–5.72 (m, 2H), 4.43 (d, J = 12.8 Hz, 1H), 4.23 (d, J = 12.7 Hz, 1H), 3.69 (t, J = 7.2 Hz, 1H), 3.14 (t, J = 7.0 Hz, 1H), 2.14 (dtt, J = 11.4, 6.7, 1.2 Hz, 1H), 1.56 (d, J = 11.4 Hz, 1H), 1.11 (s, 9H), 0.01 (s, 9H). 13C NMR (75 MHz, CDCl3): δ 147.7, 139.2, 138.9, 135.7, 135.7, 135.6, 133.7, 133.7, 133.2, 129.6, 127.6, 127.6, 124.3, 123.5, 60.4, 48.5, 46.4, 30.8, 26.9, 19.3, 0.4. HRMS (ESI+): m/z calcd for C29H38NaOSi2 [M + Na]+, 481.2353; found, 481.2378.

tert-Butyl(((1R*,6S*)-8-iodobicyclo[4.2.1]nona-2,4,7-trien-7-yl)methoxy)diphenylsilane (27)

N-Iodosuccinimide (2.35 g, 10.45 mmol) was added to a solution of 26 (4.00 g, 8.72 mmol) in anhydrous CH3CN (87 mL) under argon in darkness, and the resulting mixture was stirred at room temperature for 16 h. The reaction was quenched by the addition of a saturated solution of Na2S2O3 (50 mL) and the product extracted with EtOAc (3 × 60 mL). The combined organic layers were dried over MgSO4, filtered, and concentrated under reduced pressure. Purification by flash chromatography (cyclohexane/EtOAc 95/5) afforded the product as a pale yellow oil (2.52 g, 4.88 mmol, yield 56%).[33]1H NMR (500 MHz, CDCl3): δ 7.73–7.66 (m, 4H), 7.48–7.38 (m, 6H), 6.20 (ddq, J = 11.2, 7.2, 1.1 Hz, 1H), 6.11 (ddq, J = 11.2, 7.3, 1.0 Hz, 1H), 5.95 (ddd, J = 11.1, 7.5, 0.9 Hz, 1H), 5.86 (ddd, J = 11.0, 7.4, 0.9 Hz, 1H), 4.35 (d, J = 13.6, 0.8 Hz, 1H), 4.17 (d, J = 13.5 Hz, 1H), 3.50 (t, J = 7.0 Hz, 1H), 3.25 (t, J = 7.0 Hz, 1H), 2.31 (dtt, J = 11.3, 6.8, 1.2 Hz, 1H), 1.62 (d, J = 11.4 Hz, 1H), 1.10 (s, 9H). 13C NMR (101 MHz, CDCl3): δ 145.7, 139.1, 138.1, 135.6, 135.6, 133.4, 133.4, 129.7, 127.7, 125.4, 124.9, 84.5, 63.0, 52.9, 44.1, 30.8, 26.9, 19.3. HRMS (ESI+): m/z calcd for C26H29INaOSi [M + Na]+, 535.0925; found, 535.0919.

((1R*,6S*)-8-(3-(Trimethylsilyl)prop-2-yn-1-yl)bicyclo[4.2.1]nona-2,4,7-trien-7-yl)methanol (29)

A dry two-neck round-bottom flask equipped with a condenser was charged with activated magnesium tunings (583 mg, 24.0 mmol) that were covered with anhydrous THF (100 mL). Dibromoethane (0.1 mL) was added, followed by trimethylsilylpropargyl bromide (2.0 mL, 12.12 mmol). The reaction mixture was heated at 50 °C for 1 h and then cooled to room temperature and transferred via cannula to a second two-neck round-bottom flask containing a solution of 27 (1.23 g, 2.40 mmol) and Pd(PPh3)4 (138.7 mg, 0.12 mmol) in anhydrous THF (30 mL). The resulting mixture was stirred at 50 °C for 2 h and then cooled to room temperature, poured on brine (100 mL), and extracted with Et2O (2 × 100 mL). The combined organic layers were dried over MgSO4, filtered, and concentrated under reduced pressure. Purification by flash chromatography (cyclohexane/EtOAc 95/5) afforded 28 as a yellow oil that was directly taken to the next step due to its low stability. 1H NMR (400 MHz, CDCl3): δ 7.72–7.67 (m, 4H), 7.47–7.36 (m, 6H), 6.27–6.18 (m, 1H), 6.17–6.09 (m, 1H), 5.83–5.71 (m, 2H), 4.33 (d, J = 12.8 Hz, 1H), 4.20 (d, J = 13.0 Hz, 1H), 3.42 (t, J = 7.0 Hz, 1H), 3.36 (t, J = 7.0 Hz, 1H), 2.95 (d, J = 19.4 Hz, 1H), 2.85 (d, J = 18.6 Hz, 1H), 2.26 (dtt, J = 11.3, 6.7, 1.2 Hz, 1H), 1.61 (d, J = 11.3 Hz, 1H), 1.08 (s, 9H), 0.16 (s, 9H). 13C NMR (101 MHz, CDCl3): δ 140.2, 139.7, 135.6, 135.6, 135.0, 133.7, 133.6, 129.9, 129.6, 129.6, 127.7, 127.7, 124.4, 124.1, 104.8, 85.0, 58.5, 46.6, 45.0, 30.3, 26.8, 19.2, 17.2, 0.1. To a solution of 28 (646.0 mg, 1.30 mmol) in THF (12 mL) in a Teflon flask was added HF·py (70% weight, 0.31 mL, 12.1 mmol), and the resulting mixture was stirred at room temperature for 16 h. The reaction was quenched by the slow addition of a saturated solution of NaHCO3 (10 mL), and the product was extracted with Et2O (2 × 10 mL). The combined organic layers were dried over MgSO4, filtered, and concentrated under reduced pressure. Purification by flash chromatography (cyclohexane/EtOAc 8/2) afforded the product as a yellow oil (528.1 mg, 1.06 mmol, yield over two steps 44%). 1H NMR (400 MHz, CDCl3): δ 6.31–6.19 (m, 2H), 5.87–5.78 (m, 2H), 4.29 (d, J = 12.7 Hz, 1H), 4.19 (d, J = 12.7 Hz, 1H), 3.37 (d, J = 7.2 Hz, 1H), 3.34 (d, J = 7.2 Hz, 1H), 3.17 (d, J = 19.3 Hz, 1H), 3.11 (d, J = 19.1 Hz, 1H), 2.27 (dtt, J = 11.4, 6.7, 1.2 Hz, 1H), 1.61 (d, J = 11.4 Hz, 1H), 0.18 (s, 9H). 13C NMR (101 MHz, CDCl3): δ 139.8, 139.4, 135.1, 131.5, 124.7, 124.5, 104.4, 85.4, 57.3, 46.7, 45.4, 30.1, 17.2, 0.0. HRMS (ESI+): m/z calcd for C16H22NaOSi [M + Na]+, 281.1332; found, 281.1322.

((1R*,6S*,7R*,9S*)-9-(3-(Trimethylsilyl)prop-2-yn-1-yl)tricyclo[4.3.1.07,9]deca-2,4-dien-7-yl)methanol (30)

To a solution of 29 (430 mg, 1.66 mmol) in anhydrous CH2Cl2 (83 mL) were sequentially added CH2I2 (0.15 mL, 1.99 mmol) and ZnEt2 (1.0 M in hexanes, 4.15 mL, 4.15 mmol), and the resulting solution was stirred at room temperature for 3 h. The reaction mixture was quenched by the slow addition of a saturated aqueous Na/K-tartrate solution (100 mL), and after the mixture was stirred for 30 min, the organic layer was separated, the aqueous layer was extracted with CH2Cl2 (100 mL), and the combined organic phases were dried over MgSO4 and concentrated under reduced pressure. Purification by flash chromatography (cyclohexane/EtOAc 8/2) afforded the product as a pale yellow oil (378.0 mg, 1.39 mmol, yield 84%). 1H NMR (400 MHz, CDCl3): δ 6.11–6.00 (m, 2H), 5.84–5.70 (m, 2H), 3.92 (d, J = 11.6 Hz, 1H), 3.57 (d, J = 11.5 Hz, 1H), 2.89 (dd, J = 17.3, 0.8 Hz, 1H), 2.85–2.75 (m, 2H), 2.07 (d, J = 17.3 Hz, 1H), 1.99 (ddd, J = 12.8, 7.0, 5.7 Hz, 1H), 1.74 (d, J = 13.1 Hz, 1H), 1.50 (s, 1H), 0.74 (d, J = 5.7 Hz, 1H), 0.18 (s, 10H). 13C NMR (101 MHz, CDCl3): δ 136.9, 136.5, 125.7, 125.3, 105.4, 85.8, 64.0, 43.1, 42.3, 41.4, 38.9, 26.2, 21.0, 14.3, 0.1. HRMS (ESI+): m/z calcd for C17H24NaOSi [M + Na]+, 295.1489; found, 295.1482.

tert-Butyldimethyl(((1R*,6S*,7R*,9R*)-9-(prop-2-yn-1-yl)tricyclo[4.3.1.07,9]deca-2,4-dien-7-yl)methoxy)silane (4a)

TBAF (1.0 M solution in THF, 1.53 mL, 1.53 mmol) was added to a solution of 30 (378.1 mg, 1.39 mmol) in THF (14 mL) at 0 °C, and the resulting solution was warmed to room temperature and stirred for 15 min. Then the mixture was poured on brine (30 mL) and the product was extracted with Et2O (2 × 20 mL). The combined organic layers were dried over MgSO4, filtered, and concentrated under reduced pressure. Purification by flash chromatography (cyclohexane/EtOAc 8/2) afforded ((1R*,6S*,7R*,9R*)-9-(prop-2-yn-1-yl)tricyclo[4.3.1.07,9]deca-2,4-dien-7-yl)methanol (30′) as a colorless oil (222.7 mg, 1.11 mmol, yield 80%). 1H NMR (400 MHz, CDCl3): δ 6.12–6.03 (m, 2H), 5.84–5.76 (m, 2H), 3.91 (d, J = 11.6 Hz, 1H), 3.60 (d, J = 11.6 Hz, 1H), 2.91 (ddd, J = 17.1, 2.7, 0.9 Hz, 1H), 2.84 (td, J = 6.8, 4.0 Hz, 2H), 2.04 (t, J = 2.7 Hz, 1H), 2.03–1.95 (m, 2H), 1.75 (d, J = 13.1 Hz, 1H), 1.53 (s, 1H), 0.76 (d, J = 5.7 Hz, 1H), 0.17 (d, J = 5.7 Hz, 1H). 13C NMR (101 MHz, CDCl3): δ 136.9, 136.4, 125.8, 125.3, 82.8, 69.1, 64.1, 42.8, 42.3, 41.6, 38.8, 26.1, 19.7, 14.3. HRMS (APCI+): m/z calcd for C14H17O [M + H]+, 201.1274; found, 201.1266. TBSCl (165.6 mg, 1.10 mmol) and imidazole (136.2 mg, 2.00 mmol) were added to a solution of 30′ (200.3 mg, 1.00 mmol) in CH2Cl2 (10 mL), and the mixture was stirred at room temperature for 1 h. Then it was washed with H2O (10 mL) and brine (10 mL) and the organic layer was dried over MgSO4, filtered, and concentrated under reduced pressure. Purification by column chromatography (cyclohexane) afforded the product as a colorless oil (314.4 mg, 0.99 mmol, yield 99%). 1H NMR (400 MHz, CDCl3): δ 6.06–5.92 (m, 2H), 5.79–5.69 (m, 2H), 4.08 (dd, J = 10.4, 1.1 Hz, 1H), 3.37 (d, J = 10.4 Hz, 1H), 2.85–2.73 (m, 3H), 2.04–1.94 (m, 3H), 1.72 (d, J = 13.0 Hz, 1H), 0.91 (s, 9H), 0.71 (d, J = 5.6 Hz, 1H), 0.22 (d, J = 5.7 Hz, 1H), 0.06 (s, 3H), 0.04 (s, 3H). 13C NMR (101 MHz, CDCl3): δ 136.8, 136.4, 125.3, 124.9, 83.2, 68.8, 63.0, 43.1, 42.4, 41.5, 38.3, 26.0, 25.9, 19.1, 18.3, 13.6, −5.2, −5.4. HRMS (ESI+): m/z calcd for C20H30NaOSi [M + Na]+, 337.1958; found, 337.1945.

1-((1R*,6S*,7R*,9S*)-9-(((tert-Butyldimethylsilyl)oxy)methyl)tricyclo[4.3.1.07,9]deca-2,4-dien-7-yl)propan-2-one (31)

Gold(I) complex (0.002 mmol) was added to a solution of 4a (0.1 mmol) in MeOH (1 mL), and the resulting mixture was stirred at room temperature for 2 h before the addition of 1 drop of Et3N. Then the volatiles were removed under reduced pressure, and purification by column chromatography afforded the product in 22–47% yield. 1H NMR (400 MHz, CDCl3): δ 5.98–5.83 (m, 2H), 5.77–5.69 (m, 2H), 4.09 (d, J = 10.6 Hz, 1H), 3.37 (d, J = 10.4 Hz, 1H), 3.01 (d, J = 16.1 Hz, 1H), 2.76 (t, J = 7.2 Hz, 1H), 2.73 (t, J = 6.7 Hz, 1H), 2.18 (s, 3H), 2.14 (d, J = 16.0 Hz, 1H), 2.04–1.95 (m, 1H), 1.71 (d, J = 13.0 Hz, 1H), 0.91 (s, 9H), 0.79 (d, J = 5.7 Hz, 1H), 0.21 (d, J = 5.7 Hz, 1H), 0.06 (s, 3H), 0.06 (s, 3H). 13C NMR (101 MHz, CDCl3): δ 208.9, 136.6, 136.5, 125.2, 125.1, 63.1, 43.7, 42.9, 41.8, 41.0, 35.6, 30.2, 26.4, 25.9, 18.3, 13.9, −5.2, −5.4. HRMS (ESI+): m/z calcd for C20H32NaO2Si [M + Na]+, 355.2064; found, 355.2056.

Synthesis of 4b,c

Ethynylmagnesium bromide (0.5 M in THF, 8.07 mL, 4.04 mmol) was added to a solution of 9 (3.67 mmol) in anhydrous THF (37 mL) at 0 °C. After it was stirred at room temperature for 30 min, the reaction mixture was diluted with Et2O (15 mL) and quenched by the addition of saturated NH4Cl aqueous solution (50 mL). The aqueous layer was extracted with Et2O (2 × 40 mL), the combined organic phases were dried over MgSO4, filtered, and concentrated under reduced pressure, and the resulting crude was purified by column chromatography (cyclohexane/EtOAc 7/3).

1-((1R*,6S*,7R*,9S*)-9-(Methoxymethyl)tricyclo[4.3.1.07,9]deca-2,4-dien-7-yl)prop-2-yn-1-ol (4b)

Pale yellow solid (769.2 mg, 3.34 mmol, yield 91%). Mp: 82–84 °C. 1H NMR (400 MHz, CDCl3): δ 6.10–5.99 (m, 2H), 5.84–5.72 (m, 2H), 4.94 (s, 1H), 3.87 (dd, J = 10.1, 0.7 Hz, 1H), 3.68 (d, J = 10.1 Hz, 1H), 3.37 (s, 3H), 2.97 (s, 1H), 2.82 (dd, J = 7.1, 6.2 Hz, 1H), 2.76 (dd, J = 7.1, 6.2 Hz, 1H), 2.54 (d, J = 2.2 Hz, 1H), 2.12–2.03 (m, 1H), 1.76 (d, J = 13.0 Hz, 1H), 0.76 (d, J = 5.9 Hz, 1H), 0.74 (d, J = 6.1 Hz, 1H). 13C NMR (101 MHz, CDCl3): δ 137.2, 136.0, 126.2, 125.0, 84.0, 73.5, 72.0, 61.1, 58.7, 43.8, 43.3, 43.0, 40.2, 26.3, 10.6. HRMS (APCI+): m/z calcd for C15H18NaO2 [M + Na]+, 253.1199; found, 253.1211.

1-((1R*,6S*,7R*,9S*)-9-((Benzyloxy)methyl)tricyclo[4.3.1.07,9]deca-2,4-dien-7-yl)prop-2-yn-1-ol (4c)

Colorless oil (923.0 mg, 3.01 mmol, yield 82%). 1H NMR (500 MHz, CDCl3): δ 7.39–7.33 (m, 4H), 7.33–7.29 (m, 1H), 6.06 (dd, J = 10.7, 7.5 Hz, 1H), 6.00 (dd, J = 9.7, 7.5 Hz, 1H), 5.80 (ddd, J = 11.3, 7.4, 0.9 Hz, 1H), 5.74 (ddd, J = 11.2, 7.4, 0.9 Hz, 1H), 4.95 (dd, J = 4.0, 2.2 Hz, 1H), 4.60 (d, J = 11.9 Hz, 1H), 4.51 (d, J = 11.9 Hz, 1H), 3.97 (d, J = 10.2 Hz, 1H), 3.80 (d, J = 10.2 Hz, 1H), 2.89 (d, J = 4.1 Hz, 1H), 2.85–2.79 (m, 2H), 2.51 (d, J = 2.2 Hz, 1H), 2.08 (dtt, J = 12.8, 6.3, 1.3 Hz, 1H), 1.77 (d, J = 13.1 Hz, 1H), 0.79–0.75 (m, 2H). 13C NMR (126 MHz, CDCl3): δ 138.1, 137.3, 136.0, 128.4, 127.7, 127.6, 126.3, 125.0, 83.9, 73.6, 73.0, 69.7, 61.2, 43.8, 43.3, 43.0, 40.3, 26.4, 11.0. HRMS (ESI+): m/z calcd for C21H22NaO2 [M + Na]+, 329.1512; found, 329.1518.

Gold-Catalyzed Cyclization of 1,6-Enynes 4b,c

Gold(I) complex B (3.1 mg, 0.002 mmol) was added to a solution of 4b,c (0.1 mmol) in ROH (1 mL), and the resulting suspension was stirred at room temperature for 2 h before the addition of 1 drop of Et3N. Then the volatiles were removed under reduced pressure and the resulting crude was purified by column chromatography to afford tetracycles 32.

(1aR*,2S*,3aS*,4S*,6R*,6aS*,7R*)-6,7-Dimethoxy-1a-(methoxymethyl)-5-methylene-1,1a,2,3,3a,4,5,6-octahydro-2,4-prop[1]enocyclopropa[c]pentalene (32a)

Purification: pentane/CH2Cl2 9/1. White solid (25.1 mg, yield 91%). 32a:32a′ > 20:1. Mp: 95–97 °C. 1H NMR (500 MHz, CDCl3): δ 6.12 (ddd, J = 11.6, 6.8, 1.5 Hz, 1H), 5.76 (ddd, J = 11.6, 7.3, 0.6 Hz, 1H), 5.17 (d, J = 2.9 Hz, 1H), 5.04 (d, J = 2.4 Hz, 1H), 3.98 (dd, J = 7.3, 3.7 Hz, 1H), 3.70 (dd, J = 9.8, 1.6 Hz, 1H), 3.47 (s, 1H), 3.41 (s, 3H), 3.36 (s, 3H), 3.36–3.29 (m, 1H), 3.33 (s, 3H), 2.90 (dd, J = 9.7, 6.6 Hz, 1H), 2.84–2.80 (m, 2H), 2.50 (d, J = 13.7 Hz, 1H), 1.42 (dtd, J = 13.6, 6.7, 1.6 Hz, 1H), 1.12 (dd, J = 5.8, 1.6 Hz, 1H), 1.08 (d, J = 5.8 Hz, 1H). 13C NMR (101 MHz, CDCl3): δ 151.2, 140.2, 127.6, 110.9, 85.7, 80.8, 74.1, 58.7, 56.6, 55.6, 45.9, 45.6, 42.8, 40.9, 36.1, 30.3, 16.0. HRMS (ESI+): m/z calcd for C17H24NaO3 [M + Na]+, 299.1618; found, 299.1626. Note: this reaction could be scaled up to obtain 400 mg of 32a without any decrease in yield or selectivity. X-ray-quality single crystals were obtained by slow evaporation of a solution of 32a in CH2Cl2 at 5 °C.

(1aR*,2S*,3aS*,4S*,6R*,6aS*,7R*)-1a-((Benzyloxy)methyl)-6,7-dimethoxy-5-methylene-1,1a,2,3,3a,4,5,6-octahydro-2,4-prop[1]enocyclopropa[c]pentalene (32b)

Purification: cyclohexane/EtOAc 1/0 to 95/5. Colorless oil (29.6 mg, yield 84%). 32b:32b′ = 5:1. Data for the major isomer are as follows. 1H NMR (500 MHz, CDCl3): δ 7.40–7.34 (m, 4H), 7.33–7.29 (m, 1H), 6.09 (ddd, J = 11.6, 6.7, 1.5 Hz, 1H), 5.72 (ddd, J = 11.6, 7.3, 0.6 Hz, 1H), 5.15 (d, J = 2.9 Hz, 1H), 5.03 (d, J = 2.4 Hz, 1H), 4.57 (d, J = 12.1 Hz, 1H), 4.52 (d, J = 12.1 Hz, 1H), 3.97 (dd, J = 7.3, 3.7 Hz, 1H), 3.78 (dd, J = 9.8, 1.5 Hz, 1H), 3.45 (d, J = 1.2 Hz, 1H), 3.41 (s, 3H), 3.32 (s, 1H), 3.32 (s, 3H), 2.96 (d, J = 9.8 Hz, 1H), 2.91 (dd, J = 10.0, 6.3 Hz, 1H), 2.87 (t, J = 6.9 Hz, 1H), 2.51 (d, J = 13.7 Hz, 1H), 1.47–1.40 (m, 1H), 1.14 (dd, J = 5.8, 1.5 Hz, 1H), 1.10 (d, J = 5.8 Hz, 1H). 13C NMR (126 MHz, CDCl3): δ 151.2, 140.2, 138.5, 128.4, 128.4, 127.6, 127.6, 110.9, 85.7, 80.8, 72.7, 71.5, 56.6, 55.6, 46.0, 45.7, 42.9, 41.0, 36.3, 30.3, 16.1. HRMS (ESI+): m/z calcd for C23H28NaO3 [M + Na]+, 375.1931; found, 375.1925.

(1aR*,2S*,3aS*,4S*,6R*,6aS*,7R*)-6,7-Bis(allyloxy)-1a-((benzyloxy)methyl)-5-methylene-1,1a,2,3,3a,4,5,6-octahydro-2,4-prop[1]enocyclopropa[c]pentalene (32c)

Purification: cyclohexane/EtOAc 1/0 to 95/5. White solid (30.0 mg, yield 84%). 32c:32c′ > 20:1. Mp: 138–140 °C. 1H NMR (500 MHz, CDCl3): δ 7.39–7.34 (m, 4H), 7.33–7.29 (m, 1H), 6.07 (ddd, J = 11.6, 6.8, 1.5 Hz, 1H), 6.01–5.88 (m, 2H), 5.69 (ddd, J = 11.6, 7.3, 0.6 Hz, 1H), 5.31 (dq, J = 17.2, 1.7 Hz, 1H), 5.26 (dq, J = 17.2, 1.7 Hz, 1H), 5.20 (dq, J = 10.4, 1.8 Hz, 1H), 5.17 (dq, J = 10.2, 1.9 Hz, 1H), 5.13 (d, J = 2.9 Hz, 1H), 4.99 (d, J = 2.4 Hz, 1H), 4.56 (d, J = 12.1 Hz, 1H), 4.51 (d, J = 12.1 Hz, 1H), 4.13 (dd, J = 7.4, 3.8 Hz, 1H), 4.09 (dt, J = 5.5, 1.5 Hz, 1H), 4.08 (dt, J = 5.7, 1.5 Hz, 1H), 4.05 (dq, J = 5.7, 1.6 Hz, 1H), 3.97 (ddt, J = 12.7, 6.0, 1.4 Hz, 1H), 3.77 (dd, J = 9.8, 1.5 Hz, 1H), 3.65 (s, 1H), 3.34 (dq, J = 9.5, 3.0 Hz, 1H), 2.96 (d, J = 6.3 Hz, 1H), 2.94 (d, J = 6.4 Hz, 1H), 2.87 (t, J = 6.7 Hz, 1H), 2.57 (d, J = 13.7 Hz, 1H), 1.48–1.42 (m, 1H), 1.16 (dd, J = 5.8, 1.5 Hz, 1H), 1.09 (d, J = 5.8 Hz, 1H). 13C NMR (126 MHz, CDCl3): δ 151.8, 140.1, 138.5, 135.4, 135.3, 128.4, 127.8, 127.6, 127.6, 116.9, 116.8, 110.8, 83.2, 78.2, 72.7, 71.5, 69.7, 68.5, 46.3, 45.7, 42.9, 41.1, 36.3, 30.3, 16.3. HRMS (ESI+): m/z calcd for C27H32NaO3 [M + Na]+, 427.2244; found, 427.2227.

((1R*,6S*,7S*,9R*)-9-(Methoxymethyl)tricyclo[4.3.1.07,9]decan-7-yl)methanol (33)

A round-bottom flask containing a solution of 8a (200 mg, 0.97 mmol) and Pd(OH)2/C (20 wt %, 28.1 mg, 0.048 mmol) in anhydrous MeOH (10 mL) was evacuated and back-filled with H2 (repeated three times). The resulting mixture was stirred at room temperature for 4 h, and then the volatiles were removed under reduced pressure and the crude was purified by column chromatography (cyclohexane/EtOAc 1/1) to afford the product as a colorless oil (204.0 mg, 0.97 mmol, yield quantitative). 1H NMR (400 MHz, CDCl3): δ 4.02 (dd, J = 11.6, 1.1 Hz, 1H), 3.79 (dd, J = 10.2, 1.0 Hz, 1H), 3.48 (d, J = 11.6 Hz, 1H), 3.37 (s, 3H), 3.27 (d, J = 10.1 Hz, 1H), 2.43–1.36 (m, 2H), 2.01–1.93 (m, 1H), 1.91–1.82 (m, 1H), 1.70–1.34 (m, 9H), 0.88 (dt, J = 4.7, 1.1 Hz, 1H), 0.52 (d, J = 4.6 Hz, 1H). 13C NMR (126 MHz, CDCl3): δ 73.6, 63.4, 58.8, 40.4, 39.8, 36.3, 34.7, 29.1, 29.1, 28.9, 25.1, 24.8, 18.4. HRMS (ESI+): m/z calcd for C13H22NaO2 [M + Na]+, 233.1512; found, 233.1511.

(R*)-1-((1R*,6S*,7S*,9R*)-9-(Methoxymethyl)tricyclo[4.3.1.07,9]decan-7-yl)prop-2-yn-1-ol (34)

Dess–Martin periodinane (524.3 mg, 1.24 mmol) was added to a solution of 33 (200 mg, 0.95 mmol) in CH2Cl2 (10 mL). After the addition of 1 drop of water the resulting suspension was stirred at room temperature for 15 min and then washed with a 1/1 mixture of saturated solution of Na2S2O3/Na2CO3 (20 mL). The organic layer was dried over MgSO4, filtered, and concentrated under reduced pressure. The product (33′) was obtained after filtration through a pad of silica gel as a colorless oil and directly submitted to the next step. 1H NMR (500 MHz, CDCl3): δ 9.44 (s, 1H), 3.86 (dd, J = 10.2, 1.3 Hz, 1H), 3.54 (d, J = 10.2 Hz, 1H), 3.39 (s, 3H), 2.66 (ddd, J = 7.3, 4.4, 2.7 Hz, 1H), 2.51–2.41 (m, 2H), 1.97–1.88 (m, 1H), 1.64–1.40 (m, 9H), 1.37 (dd, J = 4.9, 1.3 Hz, 1H). 13C NMR (126 MHz, CDCl3): δ 200.7, 71.6, 58.9, 45.5, 43.1, 39.5, 38.1, 30.2, 29.6, 27.8, 25.5, 24.3, 23.4. Ethynylmagnesium bromide (0.5 M in THF, 2.01 mL, 1.00 mmol) was added to a solution of aldehyde 33′ (190 mg, 0.91 mmol) in anhydrous THF (9 mL) at 0 °C. After it was stirred at room temperature for 30 min, the reaction mixture was diluted with Et2O (15 mL) and quenched by the addition of saturated NH4Cl aqueous solution (50 mL). The aqueous layer was extracted with Et2O (2 × 40 mL), the combined organic phases were dried over MgSO4, filtered, and concentrated under reduced pressure, and the resulting crude was purified by column chromatography (cyclohexane/EtOAc 7/3) to afford 34 as a colorless oil (208.9 mg, 0.89 mmol, yield over two steps 98%). 1H NMR (500 MHz, CDCl3): δ 4.87 (dd, J = 5.2, 2.2 Hz, 1H), 3.81 (d, J = 10.4 Hz, 1H), 3.70 (d, J = 10.3 Hz, 1H), 3.48 (d, J = 5.3 Hz, 1H), 3.36 (s, 3H), 2.51 (d, J = 2.2 Hz, 1H), 2.42 (ddd, J = 7.7, 5.3, 2.4 Hz, 1H), 2.31 (ddd, J = 7.8, 6.1, 1.9 Hz, 1H), 2.08–2.01 (m, 1H), 1.86–1.79 (m, 1H), 1.78–1.71 (m, 1H), 1.70–1.61 (m, 1H), 1.57–1.42 (m, 4H), 1.40–1.32 (m, 2H), 0.94 (d, J = 4.7 Hz, 1H), 0.82 (d, J = 4.7 Hz, 1H). 13C NMR (126 MHz, CDCl3): δ 84.5, 74.0, 72.8, 61.1, 58.4, 42.1, 41.5, 38.7, 35.8, 29.6, 29.1, 29.0, 25.2, 24.5, 16.4. HRMS (ESI+): m/z calcd for C15H22NaO2 [M + Na]+, 257.1512; found, 257.1514.

Synthesis of 4d,e

Dess-Martin periodinane (478.8 mg, 1.13 mmol) was added to a solution of 4b,c (0.87 mmol) in CH2Cl2 (9 mL). After the addition of 1 drop of water, the resulting suspension was stirred at room temperature for 1 h and then washed with a 1/1 mixture of a saturated solution of Na2S2O3/Na2CO3 (40 mL). The organic layer was dried over MgSO4, filtered, and concentrated under reduced pressure. The product was obtained after purification by flash chromatography (cyclohexane/EtOAc 7/3).

1-((1R*,6S*,7R*,9S*)-9-(Methoxymethyl)tricyclo[4.3.1.07,9]deca-2,4-dien-7-yl)prop-2-yn-1-one (4d)

Yellow oil (121.2 mg, 0.53 mmol, yield 61%). 1H NMR (400 MHz, CDCl3): δ 6.32 (ddd, J = 11.4, 7.4, 1.1 Hz, 1H), 6.02 (ddd, J = 11.2, 7.7, 0.9 Hz, 1H), 5.79 (ddd, J = 11.5, 7.4, 0.8 Hz, 1H), 5.70 (ddd, J = 11.4, 7.4, 0.8 Hz, 1H), 4.02 (dd, J = 10.1, 1.5 Hz, 1H), 3.82 (d, J = 10.1 Hz, 1H), 3.42 (s, 3H), 3.26 (s, 1H), 3.12–3.06 (m, 1H), 2.91 (t, J = 7.0 Hz, 1H), 2.06–1.98 (m, 1H), 1.85 (dd, J = 13.2, 0.6 Hz, 1H), 1.34 (dd, J = 5.5, 1.4 Hz, 1H), 1.26 (d, J = 5.5 Hz, 1H). 13C NMR (126 MHz, CDCl3): δ 185.7, 136.9, 134.8, 125.5, 124.1, 82.0, 79.1, 71.4, 58.8, 52.3, 45.5, 41.7, 40.4, 25.6, 22.5. HRMS (ESI+): m/z calcd for C15H16NaO2 [M + Na]+, 251.1043; found, 251.1035.

1-((1R*,6S*,7R*,9S*)-9-((Benzyloxy)methyl)tricyclo[4.3.1.07,9]deca-2,4-dien-7-yl)prop-2-yn-1-one (4e)

Yellow oil (174.9 mg, 0.57 mmol, yield 66%). 1H NMR (500 MHz, CDCl3): δ 7.42–7.34 (m, 4H), 7.34–7.29 (m, 1H), 6.32 (ddq, J = 11.3, 7.6, 0.7 Hz, 1H), 5.97 (ddq, J = 11.4, 7.5, 1.0 Hz, 1H), 5.75 (ddd, J = 11.3, 7.4, 0.8 Hz, 1H), 5.67 (ddd, J = 11.4, 7.3, 0.8 Hz, 1H), 4.61 (d, J = 11.9 Hz, 1H), 4.58 (d, J = 12.0 Hz, 1H), 4.10 (dd, J = 10.1, 1.5 Hz, 1H), 3.95 (d, J = 10.0 Hz, 1H), 3.11 (s, 1H), 3.07 (t, J = 7.1 Hz, 1H), 2.98 (t, J = 7.0 Hz, 1H), 2.02 (dtt, J = 13.0, 6.4, 1.3 Hz, 1H), 1.85 (d, J = 14.0 Hz, 1H), 1.35 (dd, J = 5.6, 1.4 Hz, 1H), 1.27 (d, J = 5.6 Hz, 1H). 13C NMR (126 MHz, CDCl3): δ 185.7, 138.5, 137.0, 134.7, 128.4, 127.8, 127.6, 125.5, 124.0, 81.7, 79.2, 73.0, 68.9, 52.6, 45.7, 41.8, 40.4, 25.5, 22.5. HRMS (ESI+): m/z calcd for C21H20NaO2 [M + Na]+, 327.1356; found, 327.1363.

Gold-Catalyzed Cyclizations of 1,6-Enynes 4d,e

Gold(I) complex B (3.1 mg, 0.002 mmol)[31] was added to a solution of 4d,e (0.1 mmol) in ROH (1 mL) or a 2/1 dioxane/H2O mixture (2 mL), and the resulting suspension was stirred at room temperature for the appointed time before the addition of 1 drop of Et3N. Then the volatiles were removed under reduced pressure and purification by preparative TLC afforded the tetracyclic products 39′/39″.

(1aR*,2S*,3aS*,4S*,6aS*,7R*)-1a-((Benzyloxy)methyl)-7-methoxy-5-methylene-1a,2,3,3a,4,5-hexahydro-2,4-prop[1]enocyclopropa[c]pentalen-6(1H)-one (39a′)

General procedure starting from 4e and methanol. Reaction time: 1 h. Purification: cyclohexane/EtOAc 95/5 (eluted three times). White solid (15.1 mg, yield 45%). Mp: 59–61 °C. 1H NMR (400 MHz, CDCl3): δ 7.40–7.28 (m, 5H), 6.14–6.07 (m, 2H), 5.72 (dd, J = 11.8, 7.2 Hz, 1H), 5.33 (dd, J = 2.2, 0.6 Hz, 1H), 4.58 (d, J = 11.9 Hz, 1H), 4.44 (d, J = 12.0 Hz, 1H), 3.82 (ddd, J = 7.3, 3.1, 0.7 Hz, 1H), 3.68 (dd, J = 10.0, 1.9 Hz, 1H), 3.54–3.48 (m, 1H), 3.44 (s, 3H), 3.07 (d, J = 9.9 Hz, 1H), 3.03 (t, J = 6.6 Hz, 1H), 2.89 (dd, J = 9.3, 7.2 Hz, 1H), 2.74 (d, J = 13.9 Hz, 1H), 1.87 (d, J = 5.7 Hz, 1H), 1.68 (dtd, J = 13.9, 6.9, 1.7 Hz, 1H), 1.52 (dd, J = 5.8, 1.8 Hz, 1H). 13C NMR (101 MHz, CDCl3): δ 201.7, 147.6, 140.4, 138.3, 128.4, 127.7, 127.7, 127.1, 118.0, 82.7, 73.1, 70.5, 56.6, 52.7, 47.3, 45.6, 42.4, 42.0, 31.5, 22.4. HRMS (ESI+): m/z calcd for C22H24NaO3 [M + Na]+, 359.1618; found, 359.1617.

(1aR*,2R*,3aS*,4S*,6aS*,9S*)-1a-((Benzyloxy)methyl)-9-methoxy-5-methylene-1a,2,3,3a,4,5-hexahydro-4,2-prop[1]enocyclopropa[c]pentalen-6(1H)-one (39a″)

General procedure starting from 4e and methanol. Reaction time: 1 h. Purification: cyclohexane/EtOAc 95/5 (eluted three times). White solid (9.7 mg, yield 29%). Mp: 70–72 °C. 1H NMR (400 MHz, CDCl3): δ 7.40–7.29 (m, 5H), 5.92 (dd, J = 1.4, 0.7 Hz, 1H), 5.43 (ddt, J = 12.8, 4.7, 1.9 Hz, 1H), 5.34 (ddd, J = 12.9, 4.9, 0.9 Hz, 1H), 5.28 (dd, J = 1.3, 0.7 Hz, 1H), 4.60 (d, J = 11.9 Hz, 1H), 4.41 (d, J = 11.9 Hz, 1H), 3.90 (t, J = 4.0 Hz, 1H), 3.60 (t, J = 6.3 Hz, 1H), 3.52 (dd, J = 10.4, 1.8 Hz, 1H), 3.38 (s, 3H), 3.17 (d, J = 10.4 Hz, 1H), 2.83 (dt, J = 8.0, 2.6 Hz, 1H), 2.76 (t, J = 7.4 Hz, 1H), 2.29 (d, J = 14.4 Hz, 1H), 1.77 (d, J = 5.4 Hz, 1H), 1.68–1.61 (m, 1H), 1.34 (dd, J = 5.5, 1.7 Hz, 1H). 13C NMR (101 MHz, CDCl3): δ 202.1, 149.7, 138.1, 131.5, 128.4, 127.9, 127.8, 124.1, 115.5, 78.2, 73.1, 69.3, 56.9, 47.5, 47.1, 44.8, 43.6, 43.2, 26.7, 21.0. HRMS (ESI+): m/z calcd for C22H24NaO3 [M + Na]+, 359.1618; found, 359.1616.

(1aR*,2S*,3aS*,4S*,6aS*,7R*)-7-(Allyloxy)-1a-((benzyloxy)methyl)-5-methylene-1a,2,3,3a,4,5-hexahydro-2,4-prop[1]enocyclopropa[c]pentalen-6(1H)-one (39b′)

General procedure starting from 4e and allyl alcohol. Reaction time: 1.5 h. Purification: cyclohexane/EtOAc 95/5 (eluted three times). White solid (15.9 mg, yield 44%). Mp: 44–46 °C. 1H NMR (400 MHz, CDCl3): δ 7.39–7.28 (m, 5H), 6.13–6.07 (m, 2H), 5.98 (ddt, J = 17.2, 10.3, 5.6 Hz, 1H), 5.68 (dd, J = 11.7, 7.3 Hz, 1H), 5.34 (dq, J = 17.1, 1.4 Hz, 1H), 5.31–5.29 (m, 1H), 5.23 (dq, J = 10.4, 1.4 Hz, 1H), 4.58 (d, J = 11.9 Hz, 1H), 4.44 (d, J = 11.8 Hz, 1H), 4.15 (ddt, J = 12.6, 5.5, 1.5 Hz, 1H), 4.07 (ddt, J = 12.6, 5.7, 1.4 Hz, 1H), 3.97 (ddd, J = 7.3, 3.1, 0.6 Hz, 1H), 3.68 (dd, J = 10.0, 1.8 Hz, 1H), 3.50 (dq, J = 9.2, 2.5 Hz, 1H), 3.06 (d, J = 10.0 Hz, 1H), 3.06 (t, J = 6.7 Hz, 1H), 2.90 (dd, J = 9.3, 7.2 Hz, 1H), 2.80 (d, J = 13.9 Hz, 1H), 1.86 (d, J = 5.7 Hz, 1H), 1.69 (dtd, J = 13.9, 6.9, 1.7 Hz, 1H), 1.52 (dd, J = 5.7, 1.8 Hz, 1H). 13C NMR (101 MHz, CDCl3): δ 201.7, 147.7, 140.3, 138.3, 135.1, 128.4, 127.7, 127.7, 127.3, 118.0, 117.2, 80.1, 73.1, 70.5, 69.7, 52.8, 47.3, 46.0, 42.4, 42.0, 31.6, 22.4. HRMS (ESI+): m/z calcd for C24H26NaO3 [M + Na]+, 385.1774; found, 385.1780.

(1aR*,2R*,3aS*,4S*,6aS*,9S*)-9-(Allyloxy)-1a-((benzyloxy)methyl)-5-methylene-1a,2,3,3a,4,5-hexahydro-4,2-prop[1]enocyclopropa[c]pentalen-6(1H)-one (39b″)

General procedure starting from 4e and allyl alcohol. Reaction time: 1.5 h. Purification: cyclohexane/EtOAc 95/5 (eluted three times). White solid (15.1 mg, yield 42%). Mp: 67–69 °C. 1H NMR (400 MHz, CDCl3): δ 7.39–7.29 (m, 5H), 6.00–5.86 (m, 1H), 5.93–5.91 (m, 1H), 5.42 (ddt, J = 12.8, 4.6, 1.8 Hz, 1H), 5.37–5.31 (m, 1H), 5.29–5.27 (m, 1H), 5.28 (dq, J = 17.2, 1.6 Hz, 1H), 5.18 (dq, J = 10.3, 1.4 Hz, 1H), 4.57 (d, J = 11.8 Hz, 1H), 4.41 (d, J = 11.8 Hz, 1H), 4.13–4.04 (m, 2H), 3.99 (ddt, J = 12.8, 5.8, 1.4 Hz, 1H), 3.61 (t, J = 6.0 Hz, 1H), 3.52 (dd, J = 10.4, 1.8 Hz, 1H), 3.16 (d, J = 10.4 Hz, 1H), 2.84–2.79 (m, 1H), 2.77 (td, J = 7.1, 1.1 Hz, 1H), 2.36 (d, J = 14.4 Hz, 1H), 1.77 (d, J = 5.4 Hz, 1H), 1.71–1.59 (m, 1H), 1.33 (dd, J = 5.4, 1.7 Hz, 1H). 13C NMR (101 MHz, CDCl3): δ 202.1, 149.7, 138.1, 135.1, 131.5, 128.4, 127.9, 127.7, 124.5, 117.0, 115.5, 76.0, 73.2, 70.2, 69.5, 47.4, 47.1, 44.9, 43.8, 43.6, 26.8, 21.0. HRMS (ESI+): m/z calcd for C24H26NaO3 [M + Na]+, 385.1774; found, 385.1780.

(1aR*,2S*,3aS*,4S*,6aS*,7R*)-7-Hydroxy-1a-(methoxymethyl)-5-methylene-1a,2,3,3a,4,5-hexahydro-2,4-prop[1]enocyclopropa[c]pentalen-6(1H)-one (39c′) and (1aR*,2R*,3aS*,4S*,6aS*,9S*)-9-hydroxy-1a-(methoxymethyl)-5-methylene-1a,2,3,3a,4,5-hexahydro-4,2-prop[1]enocyclopropa[c]pentalen-6(1H)-one (39c″)

General procedure starting from 4d and water. Reaction time: 3 h. Purification: cyclohexane/EtOAc 6/4 (eluted twice). Colorless oil (15.5 mg, yield 63%). 39c′:39c″ = 1:2. 1H NMR (400 MHz, CDCl3): 39c′, δ 6.17 (ddd, J = 11.6, 6.8, 1.6 Hz, 1H), 6.11 (dd, J = 2.5, 0.6 Hz, 1H), 5.82 (dd, J = 11.6, 7.3 Hz, 1H), 5.40–5.32 (m, 1H), 4.38 (dd, J = 7.3, 3.1 Hz, 1H), 3.59 (dd, J = 10.1, 1.9 Hz, 1H), 3.47 (dd, J = 9.3, 2.7 Hz, 1H), 3.35 (s, 3H), 3.05–2.91 (m, 2H), 2.93 (d, J = 10.1 Hz, 1H), 2.75 (d, J = 14.2 Hz, 1H), 1.86 (d, J = 5.7 Hz, 1H), 1.79–1.66 (m, 1H), 1.50 (dd, J = 5.8, 1.9 Hz, 1H); 39c″, δ 5.94 (dd, J = 1.4, 0.6 Hz, 1H), 5.49 (ddt, J = 12.7, 4.9, 2.0 Hz, 1H), 5.39–5.33 (m, 1H), 5.30 (dd, J = 1.4, 0.6 Hz, 1H), 4.57 (t, J = 4.1 Hz, 1H), 3.62 (t, J = 6.6 Hz, 1H), 3.45 (dd, J = 10.5, 1.8 Hz, 1H), 3.33 (s, 3H), 3.03 (d, J = 10.5 Hz, 1H), 2.79 (td, J = 7.2, 1.2 Hz, 1H), 2.67 (dt, J = 8.0, 2.7 Hz, 1H), 2.30 (d, J = 14.5 Hz, 1H), 1.76 (d, J = 5.5 Hz, 1H), 1.74–1.64 (m, 1H), 1.32 (dd, J = 5.5, 1.8 Hz, 1H). 13C NMR (101 MHz, CDCl3): 39c′ + 39c″, δ 202.0, 201.6, 149.4, 147.5, 139.8, 131.2, 129.2, 126.0, 118.4, 115.7, 74.5, 72.8, 71.7, 69.0, 58.9, 58.8, 52.3, 48.2, 47.4, 47.2, 46.7, 44.7, 43.5, 42.3, 41.9, 32.1, 29.7, 26.4, 21.9, 20.9. HRMS (ESI+): m/z calcd for C15H18NaO3 [M + Na]+, 269.1148; found, 269.1139.

(1aR*,2S*,3aS*,4S*,6aS*,7R*)-1a-((Benzyloxy)methyl)-7-hydroxy-5-methylene-1a,2,3,3a,4,5-hexahydro-2,4-prop[1]enocyclopropa[c]pentalen-6(1H)-one (39d′) and (1aR*,2R*,3aS*,4S*,6aS*,9S*)-1a-((benzyloxy)methyl)-9-hydroxy-5-methylene-1a,2,3,3a,4,5-hexahydro-4,2-prop[1]enocyclopropa[c]pentalen-6(1H)-one (39d″)

General procedure starting from 4e and water. Reaction time: 5 h. Purification: cyclohexane/EtOAc 6/4 (eluted twice). Colorless oil (18.6 mg, yield 58%). 39d′:39d″ = 1:4. 1H NMR (500 MHz, CDCl3): 39d′ δ 7.38–7.31 (m, 5H), 6.10 (dd, J = 2.5, 0.6 Hz, 1H), 6.08 (ddd, J = 11.6, 6.9, 1.6 Hz, 1H), 5.76 (dd, J = 11.7, 7.3 Hz, 1H), 5.38–5.31 (m, 1H), 4.56 (d, J = 11.9 Hz, 1H), 4.44 (d, J = 11.9 Hz, 1H), 4.38–4.34 (m, 1H), 3.68 (dd, J = 10.0, 1.8 Hz, 1H), 3.47 (dq, J = 9.2, 2.1 Hz, 1H), 3.08 (d, J = 9.8 Hz, 1H), 3.05 (d, J = 6.7 Hz, 1H), 2.96 (dd, J = 9.1, 7.2 Hz, 1H), 2.74 (d, J = 14.1 Hz, 1H), 1.87 (d, J = 5.8 Hz, 1H), 1.79–1.74 (m, 1H), 1.52 (dd, J = 5.7, 1.8 Hz, 1H); 39d″, δ 7.39–7.29 (m, 6H), 5.94 (dd, J = 1.4, 0.6 Hz, 1H), 5.42 (ddt, J = 12.7, 4.7, 1.9 Hz, 1H), 5.34 (ddt, J = 12.7, 5.2, 0.9 Hz, 1H), 5.29 (dd, J = 1.3, 0.6 Hz, 1H), 4.55 (d, J = 12.0 Hz, 1H), 4.52 (s, 1H), 4.43 (d, J = 11.8 Hz, 1H), 3.64–3.59 (m, 1H), 3.53 (dd, J = 10.5, 1.7 Hz, 1H), 3.20 (d, J = 10.5 Hz, 1H), 2.82–2.77 (m, 1H), 2.73–2.69 (m, 1H), 2.29 (d, J = 14.5 Hz, 1H), 1.77 (d, J = 5.4 Hz, 1H), 1.69 (dddd, J = 14.8, 8.3, 7.1, 1.5 Hz, 1H), 1.34 (dd, J = 5.5, 1.7 Hz, 1H). 13C NMR (126 MHz, CDCl3): 39d′ + 39d″, δ 201.9, 149.4, 139.9, 138.0, 131.1, 129.8, 128.4, 128.4, 127.8, 127.74, 127.7, 127.7, 127.7, 126.1, 118.3, 115.7, 74.5, 73.2, 73.1, 70.5, 69.5, 69.1, 52.5, 48.2, 47.4, 47.3, 46.8, 45.0, 43.5, 42.4, 42.0, 32.1, 26.4, 22.1, 21.0 (2 peaks missing due to overlapping). HRMS (ESI+): m/z calcd for C21H22NaO3 [M + Na]+, 345.1461; found, 345.1459.
  23 in total

1.  Gold(I)-catalyzed enantioselective synthesis of functionalized indenes.

Authors:  Alberto Martínez; Patricia García-García; Manuel A Fernández-Rodríguez; Félix Rodríguez; Roberto Sanz
Journal:  Angew Chem Int Ed Engl       Date:  2010-06-21       Impact factor: 15.336

2.  Gold(I)-catalyzed cyclizations of 1,6-enynes: alkoxycyclizations and exo/endo skeletal rearrangements.

Authors:  Cristina Nieto-Oberhuber; M Paz Muñoz; Salomé López; Eloísa Jiménez-Núñez; Cristina Nevado; Elena Herrero-Gómez; Mihai Raducan; Antonio M Echavarren
Journal:  Chemistry       Date:  2006-02-08       Impact factor: 5.236

Review 3.  Gold and platinum catalysis--a convenient tool for generating molecular complexity.

Authors:  Alois Fürstner
Journal:  Chem Soc Rev       Date:  2009-07-22       Impact factor: 54.564

4.  Formal asymmetric synthesis of echinopine A and B.

Authors:  Philippe A Peixoto; Rene Severin; Chih-Chung Tseng; David Y-K Chen
Journal:  Angew Chem Int Ed Engl       Date:  2011-02-18       Impact factor: 15.336

5.  Evolution of propargyl ethers into allylgold cations in the cyclization of enynes.

Authors:  Eloísa Jiménez-Núñez; Mihai Raducan; Thorsten Lauterbach; Kian Molawi; César R Solorio; Antonio M Echavarren
Journal:  Angew Chem Int Ed Engl       Date:  2009       Impact factor: 15.336

6.  Total synthesis of echinopines A and B.

Authors:  K C Nicolaou; Hanfeng Ding; Jean-Alexandre Richard; David Y-K Chen
Journal:  J Am Chem Soc       Date:  2010-03-24       Impact factor: 15.419

7.  Formal Total Synthesis of Echinopines A and B via Cr(0)-Promoted [6π + 2π] Cycloaddition.

Authors:  Saptarshi De; Shilpi Misra; James H Rigby
Journal:  Org Lett       Date:  2015-06-12       Impact factor: 6.005

8.  Total syntheses of (+)-echinopine A and B: determination of absolute stereochemistry.

Authors:  Thomas Magauer; Johann Mulzer; Konrad Tiefenbacher
Journal:  Org Lett       Date:  2009-11-19       Impact factor: 6.005

9.  Echinopines A and B: sesquiterpenoids possessing an unprecedented skeleton from Echinops spinosus.

Authors:  Mei Dong; Bin Cong; Shu-Hong Yu; Françoise Sauriol; Chang-Hong Huo; Qing-Wen Shi; Yu-Cheng Gu; Lolita O Zamir; Hiromasa Kiyota
Journal:  Org Lett       Date:  2008-02-06       Impact factor: 6.005

10.  Gold(I)-Catalyzed Activation of Alkynes for the Construction of Molecular Complexity.

Authors:  Ruth Dorel; Antonio M Echavarren
Journal:  Chem Rev       Date:  2015-04-06       Impact factor: 60.622

View more
  1 in total

1.  Iron-Catalyzed Cycloisomerization and C-C Bond Activation to Access Non-canonical Tricyclic Cyclobutanes.

Authors:  Frederik Kramm; Franziska Ullwer; Benedict Klinnert; Min Zheng; Bernd Plietker
Journal:  Angew Chem Int Ed Engl       Date:  2022-08-08       Impact factor: 16.823

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.